PreveCeutical to Develop Sol-Gel N2B Platform for Parkinson's Disease

Stock Information for PreveCeutical Medical Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About PreveCeutical Medical Inc

PreveCeutical Announces Grant of Patent for Innovative Pain Therapy Technology
PreveCeutical Medical and BioGene Therapeutics Announce Closing of Plan of Arrangement
CSE Bulletin: Notice of Distribution and Reclassification - PreveCeutical Medical Inc. (PREV)
PreveCeutical Provides Clarification of News Release Announcing Update on Plan of Arrangement with BioGene Therapeutics Inc.
PreveCeutical Provides Update on Plan of Arrangement with BioGene Therapeutics Inc.
PreveCeutical Closes Second Tranche of Non-Brokered Private Placement
PreveCeutical Provides Update on Plan of Arrangement with BioGene Therapeutics Inc.
PreveCeutical Announces Results from Annual General and Special Meeting and Increase to Size of Non-Brokered Private Placement

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.